Delivery Order SPE2DB22D1202-SPE2DB25FVBK0

Award Date 6/4/25
Potential Completion Date 6/5/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fulphila 6 mg/0.6 mL syringes. The contract does not have a set-aside designation and has a ceiling value of $6,555.80. It is a firm fixed-price contract with an ultimate completion date of September 19, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,553.36, is for the delivery of FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML, a pharmaceutical product, with a performance period through March 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fulphila (pegfilgrastim-jmdb) 6 mg/0.6 mL syringes, a medication used to treat low white blood cell counts in patients receiving chemotherapy. The contract has a ceiling value of $6,314.22 and is a firm fixed-price delivery order, with a performance period through May 12, 2025. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price (FFP) delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies, including...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $49,043.14, is for the procurement of various pharmaceutical products and medical supplies, including specialty medications, generic and brand-name drugs, vaccines, syringes, vials, and other medical commodities. The contract is a Firm Fixed Price (FFP) delivery order, with a period of performance through May 6, 2024. This...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,353.74 firm fixed-price contract is for the delivery of medical products, including injectors, to support military healthcare programs. The contract has an ultimate completion date of February 20, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,273.95, is for the delivery of pharmaceutical and medical products to support military healthcare programs. It is a Firm Fixed Price contract with a final completion date of February 3, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a $16,589.43 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 14, 2025 and was not set aside for any specific business category. The award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,483.44 firm fixed-price contract has a completion date of February 13, 2025. The contract provides a range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and vaccines, to support military healthcare programs...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of a variety of pharmaceutical products and medical supplies. The $6,079.92 firm fixed price contract is not set aside and has a completion date of May 23, 2025. Amerisourcebergen also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FVBK0
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fulphila 6 mg/0.6 ml syringes. The contract has a firm fixed price of $1,006.88 and a completion date of June 5, 2025. This contract is not set-aside and was competitively awarded.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/3/25, 9:47 AM